Savara (SVRA) Non-Current Debt (2015 - 2026)
Savara's (SVRA) quarterly Non-Current Debt came in at $30.1 million in Q1 2026, up 1.84% year-on-year from $29.5 million in Q1 2025, and up 0.53% on a QoQ basis from $29.9 million in Q4 2025.
Savara (SVRA) Non-Current Debt (2015 - 2026) Analysis & Trends
Savara (SVRA) has 12 years of Non-Current Debt data on file, last reported at $30.1 million in Q1 2026.
- On a quarterly basis, Non-Current Debt rose 1.84% year-over-year to $30.1 million in Q1 2026; TTM through Mar 2026 was $30.1 million, a 1.84% increase from a year earlier, with the FY2025 full-year figure at $29.9 million, up 12.35% from the prior year.
- Non-Current Debt for Q1 2026 stood at $30.1 million, up from $29.9 million in the prior quarter.
- Over the last five years, Non-Current Debt for SVRA reached as high as $30.1 million in Q1 2026 and fell as low as $13.3 million in Q1 2022.
- Historically, Non-Current Debt has averaged $26.5 million across 5 years, with a median of $26.4 million in 2024.
- Across the five-year window, Non-Current Debt tumbled 47.28% in 2022 and surged 96.45% in 2023, its largest moves.
- Year by year, Non-Current Debt stood at $26.1 million in 2022, then advanced by 1.04% to $26.3 million in 2023, then rose by 1.03% to $26.6 million in 2024, then rose by 12.35% to $29.9 million in 2025, then increased by 0.53% to $30.1 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $30.1 million in Q1 2026, $29.9 million in Q4 2025, and $29.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 30.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.07 Mn |
| Dec 31, 2025 | 29.91 Mn |
| Sep 30, 2025 | 29.78 Mn |
| Jun 30, 2025 | 29.65 Mn |
| Mar 31, 2025 | 29.52 Mn |
| Dec 31, 2024 | 26.62 Mn |
| Sep 30, 2024 | 26.55 Mn |
| Jun 30, 2024 | 26.48 Mn |
| Mar 31, 2024 | 26.42 Mn |
| Dec 31, 2023 | 26.35 Mn |
| Sep 30, 2023 | 26.28 Mn |
| Jun 30, 2023 | 26.21 Mn |
| Mar 31, 2023 | 26.15 Mn |
| Dec 31, 2022 | 26.08 Mn |
| Sep 30, 2022 | 26.01 Mn |
| Jun 30, 2022 | 25.94 Mn |
| Mar 31, 2022 | 13.31 Mn |
| Dec 31, 2021 | 17.32 Mn |
| Sep 30, 2021 | 21.35 Mn |
| Jun 30, 2021 | 25.38 Mn |